Skip to content

Study · Non-randomized trial · n = 30 · 1985

2 results

Gonadotropin releasing hormone analogs for female contraception by inhibition of ovulation.

Nillius SJ

Journal of steroid biochemistry1 Nov 1985Cited by 2 (Europe PMC)

PMID2934581 (opens in a new tab)DOI10.1016/s0022-4731(85)80026-1 (opens in a new tab)PepBankPUB-02934581
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In regularly ovulating women, nafarelin consistently inhibited ovulation.

    In plain wordsIn regularly ovulating women, nafarelin consistently inhibited ovulation.

    Peptide
    Nafarelin
    Outcome
    DecreaseOvulation inhibition
    Study

    n = 30

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    125 or 250 micrograms once daily · intranasal · 3 monthsAs given in this study (human).

    Source sentences

    Summary
    The treatment consistently inhibited ovulation without serious side effects.
    1 context sentence
    Summary · context
    Thirty women received 125 or 250 micrograms of Nafarelin intranasally once daily for 3 months.
  2. 02HumanNon-randomized trialSafety outcome

    In regularly ovulating women, nafarelin treatment had no serious side effects.

    In plain wordsIn regularly ovulating women, nafarelin treatment had no serious side effects.

    Peptide
    Nafarelin
    Outcome
    Not applicableSerious side effects
    Study

    n = 30

    Outcome group
    Adverse events · Whole body
    Studied dose
    125 or 250 micrograms once daily · intranasal · 3 monthsAs given in this study (human).

    Source sentences

    Summary
    The treatment consistently inhibited ovulation without serious side effects.
    1 context sentence
    Summary · context
    Thirty women received 125 or 250 micrograms of Nafarelin intranasally once daily for 3 months.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:36 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.